Delivery Order SPE2DB25D3109-SPE2DB25FPKLD

Award Date 5/15/25
Potential Completion Date 5/16/25
Potential Value $7.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $36,865.27 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYTARY ER 61.25 MG-245 MG CAP 100S, a pharmaceutical product, with a period of performance through May 13, 2025. The award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,848.65, is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S, a prescription pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of February 11, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S, a pharmaceutical product, with a ceiling value of $6,625.52 and a delivery completion date of November 7, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,155.82, is a delivery order for the supply of RYTARY ER 61.25 MG-245 MG CAP 100S, a pharmaceutical product. The contract has an ultimate completion date of February 4, 2025 and is a firm fixed-price contract. This order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,187.74, is for the delivery of RYTARY ER 36.25 MG-145 MG capsules. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of July 19, 2024. The contract does not have a set-aside designation, indicating it was open to full and open competition. AmerisourceBergen holds a...
This federal contract award, valued at $7,330.94, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S, a pharmaceutical product, over a period ending on May 9, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,829.51, is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of July 9, 2024. This award is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RYTARY ER 48.75 MG-195 MG CAP 100S, a pharmaceutical product, at a ceiling value of $1,497.39. The contract is a firm fixed-price delivery order with an ultimate completion date of March 3, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,062.57, is for the delivery of RYTARY ER 61.25 MG-245 MG CAP 100S, a pharmaceutical product. The contract has an ultimate completion date of July 16, 2024, and is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,078.36 and is for the delivery of RYTARY ER 61.25 MG-245 MG CAP 100S medication. The contract is a Firm Fixed Price Delivery Order with a period of performance through May 2, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
  • SPE2DB25D3109
    Indefinite Delivery Contract
  • SPE2DB25D3109-SPE2DB25FPKLD
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S, a pharmaceutical product, with a ceiling value of $7,205.11. The contract is a Firm Fixed Price Delivery Order, with a completion date of May 16, 2025. This contract is not set aside, indicating open competition. AmerisourceBergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026 to support military healthcare programs worldwide.

Generated 8/14/25, 9:51 AM